Related content

Oral fluoropyrimidines in the treatment of colorectal cancer

By Meropol N.J.  

European Journal of Cancer, Vol. 34, Iss. 10, 1998-09 ,pp. : 1509-1513

Elsevier

Access to resources Recommend Favorite

Integrating the oral fluoropyrimidines into the management of advanced colorectal cancer

By Cunningham D.   James R.D.  

European Journal of Cancer, Vol. 37, Iss. 7, 2001-05 ,pp. : 826-834

Elsevier

Access to resources Recommend Favorite

Thymidine Phosphorylase and Fluoropyrimidines Efficacy: A Jekyl and Hyde Story

By  

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 4, Iss. 2, 2004-01 ,pp. : 71-81

Bentham Science Publishers

Access to resources Recommend Favorite

Chromosomal imbalances associated with acquired resistance to fluoropyrimidines in human colorectal cancer cells

By Hidaka S.   Yasutake T.   Fukushima M.   Yano H.   Haseba M.   Tsuji T.   Sawai T.   Yamaguchi H.   Nakagoe T.   Ayabe H.   Tagawa Y.  

European Journal of Cancer, Vol. 39, Iss. 7, 2003-05 ,pp. : 975-980

Elsevier

Access to resources Recommend Favorite

Effects of oxaliplatin and CPT-11 on cytotoxicity and nucleic acid incorporation of the fluoropyrimidines

By Patel Manish   Agarwal Ram   Ardalan Bach  

Journal of Cancer Research and Clinical Oncology, Vol. 130, Iss. 8, 2004-08 ,pp. : 453-459

Springer Publishing Company

Access to resources Recommend Favorite